Turtle power was on full display in Hollywood Thursday as four icons cemented their place in pop culture history. Literally. Leonardo, Donatello, Michaelangelo, and Raphael, aka the Teenage Mutant Ninja Turtles, had their hand prints immortalized outside the TCL Chinese Theater in Hollywood, California, alongside some…
After the “9-1-1” star debuted a new hairstyle, social media users began speculating that she might’ve had a cosmetic procedure.
Convenience food giant Nissin has formulated two new instant Cup Noodle meals with added caffeine and supplements targeted specifically to gamers. It probably goes without saying, but I will be eating nothing else from now on.
The ~$2 cups will be available in two varieties starting on September 18: Gaming Cup Noodle Energy Garlic & Black Pepper Yakisoba and Gaming Meshi Energy Ginger Keema Curry. The yakisoba features shrimp, pork, egg, and cabbage, and the curry contains ginger, onion, tomato, and pork. Am I going to mix the two together for a double shot of caffeine? Absolutely.
Both are sauce-based instead of soup-based, so “there is no need to worry about getting your hands or peripherals dirty, making them the perfect meal in between game-playing sessions.” Well, that’s a relief. And addition to the caffeine, both also contain arginine (helps the body build proteins) and niacin (helps with circulation). My goodness, it’s a miracle food! My doctor is going to be so proud of me.
[via GeekCulture and CNN]
Throughout the decades, Spider-Man has swung from one medium to another, each with varying levels of success. While he’s proven to be an especially great fit for animation, Marvel’s hero has also been no stranger to video games. The various titles that bear his name have been all over the place in terms of quality,…
Palmer Lucky, the Trump-thumping founder of the Oculus virtual reality headset is diving into the world of autonomous military aircraft. On Thursday, Anduril, Lucky’s venture-funded military tech company, unveiled its new AI-enabled, autonomous, fighter-jet-looking aircraft, which the company has dubbed “Fury.” Anduril…
For the first time in Joe Biden’s presidency, Democrats will have a majority at the Federal Communications Commission and the ability to undo a wave of Trump-era deregulation in the internet and communications industries. The Senate has confirmed Anna Gomez as the agency’s third Democratic commissioner, bringing an end to a long-standing partisan split on the panel.
Biden nominated Gomez, who is currently a State Department communications policy adviser, to the FCC in May. The president’s previous pick for the FCC’s open chair was Gigi Sohn, who withdrew from consideration in March after enduring attacks from politicians and industry lobbyists. Republicans and certain Democrats such as Sen. Joe Manchin refused to confirm Sohn, who is an advocate for affordable broadband.
However, senators found Gomez a more palatable choice and confirmed her to the panel on Thursday with a 55-43 vote. Gomez worked for the FCC in several positions over a 12-year period before moving into the private sector then onto the State Department earlier this year. She will be the FCC’s first Latina commissioner since Gloria Tristani stepped down in 2001.
Industry bodies and figures such as the Wireless Internet Service Providers Association and former FCC chair and Broadland campaign co-chair Mignon Clyburn have welcomed Gomez’s appointment. “At long last, at this critical time for the US telecommunications and media industries, we have a full roster of FCC commissioners,” Communications Workers of America President Claude Cummings Jr. told Engadget in a statement. “Anna Gomez is a dedicated public servant who is highly qualified to serve on the FCC. We are looking forward to working with her to realize the potential of the bipartisan infrastructure bill to bring affordable internet service to all Americans and to reverse the decline of local news that threatens the foundations of our democracy.“
After Gomez is sworn in, the Biden administration will be able to fulfill some of its major communications policy goals after a years-long partisan deadlock at the FCC. The agency has long had two Democratic and two Republican senators, who have often been unable to agree on policy votes since former chair Ajit Pai left the panel in January 2021.
The FCC is now expected to reverse some telecommunications sector deregulation efforts that the agency carried out under Donald Trump. Those include the potential restoration of Obama-era net neutrality rules, which the agency scrapped in 2017. In recent years, Democratic commissioners have had their hands largely tied, preventing them from taking meaningful action on issues such as internet data caps. However, the agency has still taken action on some fronts, including tackling problems such as robocallers and banning telecom equipment made by Chinese companies such as Huawei and ZTE.
The Democratic commissioners may need to act quickly to carry out agenda items on behalf of the Biden administration, however. Biden has nominated Democratic Commissioner Geoffrey Starks for a second term. His initial term expired last year, but he has remained on the panel in an acting capacity. Unless the Senate re-confirms Starks, the FCC may be back in a deadlock scenario in the not-too-distant future.
This article originally appeared on Engadget at https://www.engadget.com/anna-gomez-confirmed-as-fcc-commissioner-breaking-a-32-month-deadlock-202236997.html?src=rss
Researchers at Brigham and Women’s Hospital in Boston have developed an implant, notably as small as a grain of rice, that can test the effects of drugs on a patient’s brain tumor in real-time during surgery. Currently, monitoring the effects of drugs on a brain cancer patient during surgery is limited to intraoperative brain imaging and tissue sampling after a drug has been administered. The technique known as microdialysis currently stands as one of the more minimally invasive sampling options for testing the impact of drugs on brain tumors, but even that requires an entire catheter to be inserted into the patient’s skull cavity.
During development, researchers from Brigham and Women’s Hospital designed the device specifically to help test treatments in patients with brain cancers or gliomas, a type of tumor that originates in the brain or spinal cord. The device is designed to only remain implanted in a patient for about two to three hours while it delivers microdoses of the respective drug that is under observation. It can observe the impact of up to 20 drugs on the market for cancerous tumors, according to the researchers. Once the device is removed (sometime before the surgery ends), the surrounding tissue is returned to the lab for analysis.
In a statement published Wednesday, Pierpaolo Peruzzi, co-principal investigator and assistant professor in the Department of Neurosurgery at Brigham and Women’s Hospital said that knowing the impact of cancer drugs on these tumors is critical. “We need to be able to understand, early on, which drug works best for any given patient,” he said.
During the development process, researchers at the Brigham and Women’s Hospital ran a clinical trial to observe the actual impact of the implant on real patients. The study found that none of the patients in the trial experienced any adverse effects. The researchers were able to collect biological data from the devices, such as what molecular changes happened when each drug was administered. While the study demonstrated that the implant could be easily incorporated into surgical practice, the researchers are still determining how the data it can gather should be used to optimize tumor therapy.
The researchers are now conducting another study that focuses on implanting the device through a minimally invasive procedure 72 hours before their main surgery. Advancements in the cancer treatment space continue to expand, with new iterations of drug cocktails and viruses that can fight cancer cells emerging in the biotech space. Implants like the one developed by the Brigham and Women’s Hospital bring scientists one step closer to better being able to use tools and data to provide more personalized care treatment plans for cancer patients.
This article originally appeared on Engadget at https://www.engadget.com/an-experimental-rice-sized-implant-monitors-how-drugs-affect-tumors-210038580.html?src=rss
The proposed tax, if it becomes law, would be 11% — matching the highest tax imposed by the federal government on guns.
Convenience food giant Nissin has formulated two new instant Cup Noodle meals with added caffeine and supplements targeted specifically to gamers. It probably goes without saying, but I will be eating nothing else from now on.
The ~$2 cups will be available in two varieties starting on September 18: Gaming Cup Noodle Energy Garlic & Black Pepper Yakisoba and Gaming Meshi Energy Ginger Keema Curry. The yakisoba features shrimp, pork, egg, and cabbage, and the curry contains ginger, onion, tomato, and pork. Am I going to mix the two together for a double shot of caffeine? Absolutely.
Both are sauce-based instead of soup-based, so “there is no need to worry about getting your hands or peripherals dirty, making them the perfect meal in between game-playing sessions.” Well, that’s a relief. And addition to the caffeine, both also contain arginine (helps the body build proteins) and niacin (helps with circulation). My goodness, it’s a miracle food! My doctor is going to be so proud of me.
[via GeekCulture and CNN]
We’ve known for a while that Hasbro’s latest Star Wars crowdfunder—first launched at San Diego Comic-Con this summer—had successfully reached its initial goal to turn the iconic freighter of Rebels and Ahsoka’s Hera Syndulla, the Ghost, into a huge new toy. But now the campaign is over—and we know Hera will be…
This is site is run by Sascha Endlicher, M.A., during ungodly late night hours. Wanna know more about him? Connect via Social Media by jumping to about.me/sascha.endlicher.
